A lack of framework for the validation of in silico models is a major barrier to those software industries engaged in healthcare. The Avicenna Alliance will work towards the creations of such a framework that would allow for maximum market uptake of medical software for pre-clinical and clinical use.
Data Protection and ensuring ease of access to health data for medical research purposes is a key priority of the Alliance.
What if medical devices could be tested on hundreds of virtual humans before being tested on a single real one?
The Avicenna Alliance is delighted to celebrate a major milestone: the In Silico book has reached 100,000 accesses!
What a week in Milan! VPH2026 brought together around 650 experts from across the global in silico medicine community, creating an inspiring forum for exchange, collaboration and new ideas.
Fill in the fields you find below
